BOSTON SCIENTIFIC CORPORATION Stockholders' Equity Attributable to Noncontrolling Interest
BOSTON SCIENTIFIC CORPORATION (BSX) had Stockholders' Equity Attributable to Noncontrolling Interest of $242.00 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:MinorityInterest · last filed 2026-08-03
- 2026-06-30: Stockholders' Equity Attributable to Noncontrolling Interest $242.00M.
- 2026-03-31: Stockholders' Equity Attributable to Noncontrolling Interest $240.00M.
- 2025-12-31: Stockholders' Equity Attributable to Noncontrolling Interest $239.00M.
- 2025-09-30: Stockholders' Equity Attributable to Noncontrolling Interest $236.00M.
| Period end | Stockholders' Equity Attributable to Noncontrolling Interest |
|---|---|
| 2026-06-30 | $242.00M 10-Q · filed 2026-08-03 |
| 2026-03-31 | $240.00M 10-Q · filed 2026-05-01 |
| 2025-12-31 | $239.00M 10-Q · filed 2026-08-03 |
| 2025-09-30 | $236.00M 10-Q · filed 2025-11-03 |
| 2025-06-30 | $235.00M 10-Q · filed 2025-08-01 |
| 2025-03-31 | $233.00M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $233.00M 10-K · filed 2026-02-17 |
| 2024-09-30 | $248.00M 10-Q · filed 2024-11-01 |
| 2024-06-30 | $238.00M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $242.00M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $248.00M 10-K · filed 2025-02-18 |
| 2023-09-30 | $243.00M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $259.00M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $259.00M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $0.00 10-K · filed 2024-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |